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Abstract
Central obesity, measured by waist circumference (WC) or waist-hip ratio (WHR), is a marker of body fat distribution.
Although obesity disproportionately affects minority populations, few studies have conducted genome-wide association
study (GWAS) of fat distribution among those of predominantly African ancestry (AA). We performed GWAS of WC and WHR,
adjusted and unadjusted for BMI, in up to 33,591 and 27,350 AA individuals, respectively. We identified loci associated with
fat distribution in AA individuals using meta-analyses of GWA results for WC and WHR (stage 1). Overall, 25 SNPs with single
genomic control (GC)-corrected p-values,5.061026 were followed-up (stage 2) in AA with WC and with WHR. Additionally,
we interrogated genomic regions of previously identified European ancestry (EA) WHR loci among AA. In joint analysis of
association results including both Stage 1 and 2 cohorts, 2 SNPs demonstrated association, rs2075064 at LHX2,
p= 2.2461028 for WC-adjusted-for-BMI, and rs6931262 at RREB1, p= 2.4861028 for WHR-adjusted-for-BMI. However, neither
signal was genome-wide significant after double GC-correction (LHX2: p = 6.561028; RREB1: p = 5.761028). Six of fourteen
previously reported loci for waist in EA populations were significant (p,0.05 divided by the number of independent SNPs
within the region) in AA studied here (TBX15-WARS2, GRB14, ADAMTS9, LY86, RSPO3, ITPR2-SSPN). Further, we observed
associations with metabolic traits: rs13389219 at GRB14 associated with HDL-cholesterol, triglycerides, and fasting insulin,
and rs13060013 at ADAMTS9 with HDL-cholesterol and fasting insulin. Finally, we observed nominal evidence for sexual
dimorphism, with stronger results in AA women at the GRB14 locus (p for interaction = 0.02). In conclusion, we identified
two suggestive loci associated with fat distribution in AA populations in addition to confirming 6 loci previously identified in
populations of EA. These findings reinforce the concept that there are fat distribution loci that are independent of
generalized adiposity.
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Introduction
Obesity is an important public health problem, reaching
epidemic proportions. The prevalence varies by ethnicity, with
nearly one-third of European ancestry (EA) and almost one-half of
African ancestry (AA) Americans considered obese [1]. Recent
studies have suggested that body fat distribution, above and beyond
generalized adiposity, is an important metric of metabolic health, as
different fat compartments are associated with differential metabolic
risk [2]. Specifically, a tendency to deposit fat centrally is associated
with diabetes, hypertension, and heart disease [3–6], even after
accounting for generalized adiposity [7,8].
Waist circumference (WC) and waist to hip ratio (WHR) are
established measures of body fat distribution [9] that differ by
ethnicity [10,11] and demonstrate a genetic component. Twin studies
documented heritability of levels for WC and WHR in EA and AA
individuals, ranging from 31%–76% [12–15] even after accounting
for BMI [14–16]. A recent meta-analysis of WHR in EA individuals
identified 14 loci for body fat distribution [17]. In addition, recent
studies among EAs for percent body fat, fatty liver, visceral fat, and
pericardial fat reported unique loci for fat distribution and ectopic fat
depots above and beyond those associated with generalized adiposity
[18–21]. Similar studies are not available in AA populations. Thus,
the purpose of the present analysis was to perform a collaborative
large-scale meta-analysis of waist-based traits in AA individuals.
Results
We analyzed genetic loci for waist circumference (WC) and waist
hip ratio (WHR) in up to 23,564 AA participants in the discovery set
(Stage 1) and 10,027 AA participants in the replication set (Stage 2).
Table 1 presents overall study sample characteristics and Supple-
mentary Table S1 presents stratified sample characteristics by
gender. Detailed descriptions of each cohort are shown in
GWAS of Body Fat Distribution in African Ancestry
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Supplementary Table S2 and the Supplementary Materials
Text S1. In our GWAS analysis, we applied single genomic control
(GC) correction to avoid the overly conservative double GC
correction [22,23] but we also provide double GC-corrected p-values
for the joint meta-analysis of stage 1 and stage 2 samples (Table 2).
Stage1Genome-WideAssociationAnalyses forWCandWHR
We conducted genome-wide association analyses for 3.2 million
variants, including genotyped and imputed variants, among AA
individuals for WC, WC adjusted for BMI (WC-BMI), WHR and
WHR adjusted for BMI (WHR-BMI) within each cohort, overall
and by sex, and meta-analyzed the results. The Quantile-Quantile
and Manhattan plots for all analyses are displayed in Supple-
mentary Figure S1. With concern of overly conservative double
GC-correction, we applied single GC-correction p values to select
variants for follow-up. Three loci had p,561028 under single GC-
correction; rs2570467 at PCSK1 with WC, rs1345301 at IL1RL2
with WC, and rs17213965 at MYH11 with WHR-BMI, all in men
(n= 5967, 5973, 4398, respectively). Across all traits analyzed, an
additional 22 independent SNPs had a single GC-corrected
p,5.061026 (Table 2). Heterogeneity tests were examined across
all cohorts and none of these 25 SNPs were significant (all p-
values.0.05/25) in heterogeneity testing after adjusting for multiple
testing, indicating that we did not observe statistically different
allelic effects for these 25 SNPs across the participating studies.
Stage 2 Analyses and Joint Meta-Analysis of Stage 1 and
Stage 2
We carried forward all 25 SNPs with single GC-corrected
p,561026 from stage 1 and tested their association in Stage 2
with the traits of interest either in the gender-specific or gender-
combined data depending on the findings in Stage 1, in up to
10,027 AA individuals with WC and 7,606 AA individuals with
WHR. Significance was defined as the joint meta-analysis of stage
1 and stage 2 p-value,561028. Results for these SNPs from
discovery, validation and joint analyses are shown in Table 2, and
the imputation quality for these SNPs is provided in Supple-
mentary Table S3. Three SNPs with p,561028 in the men
only analysis of Stage 1 failed to replicate (p.561028, n,6,000 in
stage 1 and n,3,250 in stage 2) but two of the 25 SNPs carried
forward from Stage 1 reached genome-wide significance under
single genomic control (GC) in the joint meta-analysis of Stage 1
and Stage 2 data: rs2075064 (LHX2, p = 2.2461028) in association
with WC-BMI, and rs6931262 (RREB1, p = 2.4861028) in
association with WHR-BMI. We note, however, that double
GC-corrected p values for these two variants have slightly
attenuated p-values: rs2075064 (LHX2, p = 6.561028) and
rs6931262 (RREB1, p = 5.761028), which were no longer
genome-wide significant. The regional association plots for these
two loci are presented in Figure 1. The lead SNP rs6931262 at
RREB1 is 474 kb away from rs1294421 at LY86, previously
identified in the Genetic Investigation of ANthropomorphic Traits
(GIANT) consortium [17] of EA studies in association with WHR-
BMI (r2 = 0.007, D9=0.093 among YRI Hapmap participants).
Further Characterization of LHX2 and RREB1 Loci
Given the tendency of waist-associated SNPs to exhibit sex-
specific effects in samples of EA [17], we first tested the two AA
waist loci for evidence of sexual dimorphism (Supplementary
Table S4). There was no appreciable difference between the beta
coefficients for the lead SNPs at LHX2 or RREB1 in women
compared to men in the joint analysis of Stage 1 and Stage 2
samples (psex difference .0.46), suggesting little to no sexual
dimorphism with respect to these 2 loci.
Next, we tested whether the loci identified in the samples of
African ancestry also demonstrate nominal associations in samples
of European ancestry. We interrogated the evidence for associa-
tion, both directional consistency and statistical significance, of
these two SNPs in the GIANT consortium meta-analysis of WHR-
BMI (n = 77,167 EA participants, http://www.broadinstitute.org/
collaboration/giant/index.php/GIANT_consortium) [17]. Nei-
ther rs2075064 at LHX2 (p = 0.78) nor rs6931262 at RREB1
(p = 0.13) was statistically significant. The direction of effect for the
risk allele was consistent for RREB1 between EA and AA samples,
while it was direction-inconsistent for LHX2. However, because
linkage disequilibrium patterns with causal SNPs can differ, or
allelic heterogeneity can exist across ethnicities, we tested for SNP
associations within the 250 kb flanking genomic regions centered
at our two top signals to examine whether SNPs in these genomic
regions might be associated with WHR-BMI in EA samples. For
the LHX2 region, the SNP with the lowest p-value was rs10986172
(MAF=0.06, p = 2.661022,,30 kb from rs2075064; Figure 2a),
which did not reach the Bonferroni-corrected p-value threshold of
6.0261024 (0.05/83 independent tests). For the RREB1 region,
the SNP with the lowest p-value in the European Ancestry data
was rs9392863 (MAF=0.26, p = 1.3061024, ,20 kb from
rs6931262, LD with rs6931262: r2 = 0.005 and D9=1.00 in
HapMap CEU; Figure 2b) which met the Bonferroni-corrected
threshold of 6.1061024 (0.05/82) in EA samples. Note that the
association for rs9392863 was not significant (p-value = 0.57, LD
with rs6931262: r2 = 0.001 and D9=1.00 in HapMap YRI) in our
AA samples.
Waist circumference may be greater in tall adults. To
distinguish the evidence of association with WC-BMI from height,
we also tested whether rs2075064 at LHX2 might also be
associated with height in the GIANT GWAS of Height (http://
www.broadinstitute.org/collaboration/giant/index.php/GIANT_
consortium) [23]. No evidence of association was noted (p-value of
0.95).
Local Ancestry Analysis
Recently admixed individuals, such as samples of African
ancestry, may have inherited ancestry from more than one
ancestral population. However, local ancestry may be confounded
with the association signal and lead to spurious association in
association analysis. So to further characterize the differences by
ancestral groups of our two novel loci (LHX2 and RREB1), we
Author Summary
Central obesity is a marker of body fat distribution and is
known to have a genetic underpinning. Few studies have
reported genome-wide association study (GWAS) results
among individuals of predominantly African ancestry (AA).
We performed a collaborative meta-analysis in order to
identify genetic loci associated with body fat distribution
in AA individuals using waist circumference (WC) and waist
to hip ratio (WHR) as measures of fat distribution, with and
without adjustment for body mass index (BMI). We
uncovered 2 genetic loci potentially associated with fat
distribution: LHX2 in association with WC-adjusted-for-BMI
and at RREB1 for WHR-adjusted-for-BMI. Six of fourteen
previously reported loci for waist in EA populations were
significant in AA studied here (TBX15-WARS2, GRB14,
ADAMTS9, LY86, RSPO3, ITPR2-SSPN). These findings rein-
force the concept that there are loci for body fat
distribution that are independent of generalized adiposity.
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performed a sensitivity analysis by additionally adjusting for local
ancestry to account for the effect on our trait of interest due to the
local ancestry at the tested variant using 5 Stage 1 African ancestry
studies. Local ancestry adjustment resulted in similar effect
estimates (Supplementary Table S5), suggesting it is unlikely
to account for our reported signals.
Interrogation of Known European WHR Loci in African
Ancestry Participants
Given the association of the RREB1 locus with WHR-BMI in
both AA and EA participants, we next examined fourteen
previously published loci in association with WHR-BMI in EA
participants [17] in our AA sample (Table 3). Twelve (except
rs6861681 and rs1055144) of the fourteen SNPs had the same
effect direction with respect to the beta coefficient (binomial
distribution p-value = 0.0065), and five demonstrated nominal
significance (p,0.05) in our AA Stage 1 sample (p-value range
1.661022 to 8.561025). We also conduct two-sample t-test to
compare the beta coefficients between EA samples and AA
samples. None of these fourteen SNPs displayed significant
heterogeneity between the two races. We next interrogated the
flanking 250 kb genomic regions centered at each of the 14 SNPs
in our AA dataset. Of the 14 SNPs, 9 SNPs met the locus-specific
Bonferroni corrected threshold in the Stage 1 sample and were
carried forward for Stage 2 validation. In the combined Stage 1
and 2 sample, of these 9 SNPs, 6 remained significant with p-
values less than the locus-specific Bonferroni-corrected threshold
(0.05 divided by the number of independent SNPs within the
Table 1. Study sample characteristics.
Study
Sample
Size WC/
Hip
European
Ancestry % Women % Age (years) WC (cm) Hip (cm) WHR BMI
n/n median, Q1/Q3 % (n) mean (SD) mean (SD) mean (SD) mean (SD) mean (SD)
Stage 1 Cohorts
WHI-SHARe 8138/8128 NA 100 (8155) 61.6 (7.0) 91.5 (13.4) 111.2 (12.7) 0.82 (0.07) 31.0 (6.4)
HANDLS 961/961 0.16,0.11/0.22 55.4 (532) 48.5 (9.0) 98.5 (17.5) 107.5 (16.4) 0.91 (0.07) 29.9 (8.0)
MESA/SHARe (Family) 946/946 0.22, 0.12/0.30 60 (573) 58.2 (8.7) 100.6 (16.2) 110.1 (13.2) 0.91 (0.08) 30.7 (6.4)
Health ABC 1137/0 0.22, 0.12/0.33 57.2 (650) 73.4 (2.9) 100.3 (13.8) NA NA 28.6 (5.4)
GENOA 996/996 0.14, 0.09/0.21 70.4(701) 56.4 (11.2) 102.7 (17.1) 113.3 (15.0) 0.91 (0.08) 31.1 (6.8)
GeneSTAR 1081/552 0.13, 0.09/0.19 61.7 (667) 42.8 (10.4) 98.7 (17.0) 111.5 (14.6) 0.88 (0.08) 31.1 (7.3)
Family Heart Study 624/624 0.13, 0.09/0.19 65.7 (410) 53.3 (10.8) 104.1 (16.8) 114.1 (15.7) 0.92 (0.07) 32.7 (7.4)
HyperGEN 1179/1168 0.15, 0.11/0.20 66 (778) 45.1 (13.0) 102.9 (18.5) 114.4 (16.1) 0.89 (0.08) 32.4 (7.9)
HUFS 924/924 0.20, 0.14/0.27 57.9 (535) 45.5 (12.1) 95.0 (16.7) 110.2 (16.1) 0.86 (0.08) 30.2 (8.2)
CARe Studies*
ARIC 2778/2778 0.15, 0.11/0.22 63.2 (1755) 53.3 (5.8) 99.2 (15.0) 107.8 (11.9) 0.92 (0.08) 30.0 (6.0)
CARDIA 819/818 0.17, 0.12/0.23 60.9 (499) 25.4 (3.2) 79.1 (12.3) 102.1 (12.2) 0.77 (0.07) 25.7 (5.8)
CFS 468/468 0.18, 0.13/0.25 59.4 (278) 44.6 (15.2) 102.3 (20.2) 115.9 (18.3) 0.88 (0.09) 34.2 (9.5)
JHS 2132/0 0.16, 0.12/0.21 60.7 (1295) 50.0 (12.1) 101.2 (17.0) NA NA 32.3 (7.8)
MESA 1381/1381 0.19, 0.12/0.30 54.5 (753) 61.6 (9.9) 101.2 (14.5) 109.8 (11.8) 0.92 (0.08) 30.2 (5.7)
Stage 2 Cohorts
CHS 819/820 0.24, 0.16/0.36 63 (517) 72.9 (5.7) 98.8 (14.4) 104.6 (12.0) 0.94 (0.07) 28.5 (5.5)
BWHS 1499/1499 0.18, 0.11/0.25 100 (1499) 46.9 (10.1) 82.5 (13.0) 105.4 (12.9) 0.78 (0.09) 28.0 (5.7)
REGARDS_Diabetes_CASES 1136/0 0.13, 0.07/0.21 64(730) 63.4(8.7) 104.1(14.5) NA NA 30.2(7.0)
REGARDS_CONTROLS 1244/0 0.14, 0.08/0.22 64(796) 63.1(8.5) 104.2(14.3) NA NA 30.1(7.2)
SUGAR_Diabetes_CASES 865/855 0.05, 0.02/0.09 78(759) 54.1(14) 99.7 (16.7) 108.4(12.5) 0.92(0.08) 34.1(7.9)
SUGAR_CONTROLS 182/181 0.05, 0.02/0.11 72(144) 54.2(14.1) 99.5 (16.8) 114.3(12.6) 0.87(0.09) 34(7.6)
MEC Breast Cancer Cases 259/258 NA 100 (259) 71.6(8.6) 96.0(14.3) 109.1(14.0) 0.88(0.10) 28.6(5.8)
MEC Breast Cancer Controls 528/527 NA 100 (528) 70.9(8.4) 95.4(14.8) 110.2(14.3) 0.87(0.09) 28.7(6.0)
CBCS Breast Cancer Cases 626/626 NA 100 (626) 51.3(11.9) 96.6(14.2) 113.3(13.8) 0.85(0.08) 31.9(7.2)
CBCS Breast Cancer Controls 579/579 NA 100 (579) 51.8(11.4) 95.5(15.1) 114.3(13.9) 0.84(0.08) 32.3(7.5)
WCHS Breast Cancer Cases 256/259 NA 100 (259) 49.8(9.7) 101.1(16.7) 114.0(13.9) 0.88(0.08) 31.9(7.1)
WCHS Breast Cancer Controls 237/237 NA 100 (237) 49.8(9.4) 98.7(15.6) 113.0(13.7) 0.87(0.07) 31.3(7.0)
MEC Prostate Cancer Cases 542/528 NA 0 (0) 73.8(7.0) 99.5(12.4) 105.5(10.9) 0.94(0.09) 27.1(4.0)
MEC Prostate Cancer Controls 877/856 NA 0 (0) 69.6(8.5) 99.4(12.7) 105.8(12.0) 0.94(0.11) 27.3(3.8)
MDA Prostate Cancer Cases 153/153 NA 0 (0) 59.2(7.8) 100.5(13.0) 107.9(11.3) 0.93(0.06) 27.1(5.1)
MDA Prostate Cancer Controls 228/228 NA 0 (0) 59.6(8.7) 99.7(12.2) 106.9(11.2) 0.93(0.06) 29.1(5.0)
doi:10.1371/journal.pgen.1003681.t001
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Figure 1. Regional association plots based on single GC-corrected p-value for LHX2 and RREB1, Stage 1 only. MAF=minor allele
frequency. The p-values for the index SNP rs2075064 in LHX2 loci are 5.5E-8, 0.03, and 2.2E-8 for Stage 1, Stage 2 and joint analysis. The p-values for
the index SNP rs6931262 at RREB1 loci are 5.3E-8, 0.02 and 2.5E-8 for Stage 1, Stage 2 and joint analysis. The double GC-corrected p-value for the joint
analysis are 6.5E-8, 5.7E-8 and 1.8E-6 for rs2075064, rs6931262 and rs1294410, respectively.
doi:10.1371/journal.pgen.1003681.g001
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flanking region of each index SNP; TBX15-WARS2, GRB14,
ADAMTS9, LY86, RSPO3, ITPR2-SSPN, Table 4). Figure 3
presents the regional association plots of these six loci. Except for
the ITPR2-SSPN region, the five best AA SNPs were in linkage
disequilibrium, r2.0.3 (LD in HapMap II CEU), with the original
index SNPs previously reported in EA participants.
Because of the close physical proximity of rs6931262 at RREB1
and rs1294410 at LY86 (r2 0.01, D9 0.35 in YRI, 474 kb apart), we
performed a conditional analysis in the largest contributing study,
the Women’s Health Initiative. When the SNPs were tested
individually, the beta coefficient for rs6931262 was 20.054
(p = 0.0039), and for rs1294410 was 0.048 (p = 0.0145). In the
conditional analysis, the betas and p-values were not numerically
different (beta 20.052 for rs6931262 and 0.046 for rs1294410; p-
values 0.0056 and 0.0145, respectively).
Given the prior evidence for sexual dimorphism at many of
these known loci [17], we tested for evidence of sex differences at
the 6 replicating AA SNPs in the joint Stage 1 and Stage 2 samples
(Supplementary Table S4). We observed little evidence for
sexual dimorphism, with the exception of GRB14, which
demonstrated a stronger effect size in women as compared to
men (p-value = 0.02 for the comparison of the beta coefficients).
Cross-Trait Associations
Given the evidence for association between waist-based traits
and other cardiometabolic risk factors in EA individuals [17], we
next examined whether there was similar enrichment in AA
individuals (Table 5). rs13389219 at GRB14 was associated with
HDL-cholesterol (p = 0.014) [24], triglycerides (p = 0.014) [24],
and fasting insulin (p = 0.008) [25], while rs13060013 in
ADAMTS9 was associated with HDL-cholesterol (p = 0.0009)
[24] and fasting insulin (p = 0.002) [25]. There were nominal
associations with related anthropometric traits for rs1936806 at
RSPO3 in association with BMI [26] (p = 0.003), rs2075064 at
LHX2 in association with BMI [26] (p = 0.002), and height
(p = 0.02, Christopher Haiman, personal communication).
Discussion
We identified 2 loci at LHX2 and RREB1 with p,5.061028
under single GC-correction for waist-based traits in African
ancestry individuals, which were not genome-wide significant
(p = 6.561028 and p=5.761028) with double-GC correction.
Population sub-structure may cause spurious associations in
genome-wide association studies and GC factors calculated from
Figure 2. Regional association plots for LHX2 and RREB1 in GIANT consortium with participants of European ancestry. The blue arrow
points to the index SNPs identified from the samples of African ancestry and red arrow points to the best SNPs in GIANT consortium samples of
European ancestry.
doi:10.1371/journal.pgen.1003681.g002
Table 3. Examination of index SNPs within known loci in EA in AA for trait WHR ratio adjusted for BMI.
Index SNP Results
index SNP information EA Sample AA samples
SNP chr bp (b36) Genes All1 EAF2 beta SE P-val N beta SE EAF2 P4Het
SNPs associated with waist-related trait at significant level3
rs984222 1 119305366 TBX15-WARS2 g/c 0.37 0.04 0.005 3.3E-03 19078 0.03 0.011 0.45 0.66
rs10195252 2 165221337 GRB14 t/c 0.60 0.03 0.005 8.5E-05 19654 0.05 0.012 0.28 0.78
rs6795735 3 64680405 ADAMTS9 c/t 0.41 0.03 0.005 1.6E-02 19630 0.03 0.014 0.19 0.85
rs1294421 6 6688148 LY86 g/t 0.39 0.03 0.005 6.0E-04 19625 0.04 0.012 0.74 0.46
rs9491696 6 127494332 RSPO3 g/c 0.52 0.04 0.005 6.7E-04 19642 0.04 0.011 0.39 0.70
rs718314 12 26344550 ITPR2-SSPN g/a 0.74 0.03 0.005 6.4E-01 19637 0.01 0.014 0.19 0.85
Further SNPs evaluated in follow up but not achieving significance in combined analysis3
rs4846567 1 217817340 LYPLAL1 g/t 0.28 0.04 0.005 1.4E-01 19671 0.03 0.019 0.92 0.36
rs6784615 3 52481466 NISCH-STAB1 t/c 0.94 0.05 0.010 8.8E-01 14326 0.01 0.040 0.98 0.33
rs6905288 6 43866851 VEGFA a/g 0.56 0.03 0.005 1.0E-01 19609 0.02 0.010 0.50 0.62
SNP evaluated but not achieving significance in discovery analysis3
rs1011731 1 170613171 DNM3-PIGC g/a 0.57 0.03 0.005 1.4E-01 19480 0.02 0.014 0.82 0.41
rs6861681 5 173295064 CPEB4 a/g 0.34 0.03 0.005 4.3E-01 3074 20.04 0.053 0.07 0.94
rs1055144 7 25837634 NFE2L3 t/c 0.21 0.03 0.006 5.4E-01 19606 20.01 0.022 0.06 0.95
rs1443512 12 52628951 HOXC13 a/c 0.24 0.03 0.005 5.5E-02 19644 0.02 0.011 0.57 0.57
rs4823006 22 27781671 ZNRF3-KREMEN1 a/g 0.57 0.03 0.005 8.5E-02 19444 0.02 0.011 0.69 0.49
The index SNPs is from Heid et al, Nature Genetics 2010 [17].
1effect allele/other allele.
2effect allele frequency.
3Significance classification refers to the interrogation results of best SNP in Table 4.
4p-value of heterogeneity test of beta between EA and AA samples.
doi:10.1371/journal.pgen.1003681.t003
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variants across the genome are conventionally used to scale the test
statistic [27]. However, this method was originally proposed under
the hypothesis that only a small number of causal variants underlie
complex traits. Recent studies have shown that as the number of
causal variants increases, more SNPs (in LD with causal variants)
will depart from the null distribution even in the absence of
population sub-structure [22,23]. Furthermore, the GC factor is a
function of sample size under a constant phenotypic heritability.
Therefore, double GC-correction in a large meta-analysis is
likely overly conservative. Thus, we report both single and double
GC-corrected values. rs6931262 at RREB1 is in a region
previously identified by the GIANT consortium in European
ancestry individuals, although in low linkage disequilibrium with
the variant identified in the present study. Interrogation of 14
regions previously identified by the GIANT consortium identified
6 additional SNPs associated with waist traits in AA participants.
Two of these loci at GRB14 and ADAMTS9 were also associated
with metabolic traits in AA. Finally, we observed nominal
evidence for sexual dimorphism.
These findings support prior GWAS findings that there are
genetic loci for body fat distribution which are distinct from loci
associated with generalized adiposity. The GIANT consortium
identified 14 loci in association with WHR adjusted for BMI, and
the majority was not associated with BMI [17]. Similarly, a SNP at
IRS1 was identified in association with body percent fat that was
not associated with generalized adiposity [18]. More recent
GWAS of ectopic fat depots have also identified unique loci in
association with fatty liver [19], visceral abdominal fat [20], and
pericardial fat [21]. The results from the present analysis extend
these observations to AA populations, a group at increased risk for
obesity and its complications.
Our findings add to the growing appreciation that SNPs
correlated with body fat distribution are also associated with
metabolic traits [28]. This finding contrasts with genetic loci for
BMI, which generally have not been shown to be associated with
metabolic traits [29]. In contrast to prior work [17,18,20], we
observed little evidence for sexual dimorphism in the present
analysis, with the exception of GRB14. Whereas the GIANT
consortium observed stronger effect sizes in women than men
among the majority of the 14 WHR SNPs they identified, we
observed more modest gender differences and in some instances,
the effect size was actually stronger in men as compared to women
(ITPR2-SSPN and LHX2). This raises several hypotheses that
warrant some speculation as to why we did not observe similar
sexual dimorphism in AA sample as observed in our prior work in
EA samples. First, biologically, associations linking the SNPs and
gene regions to body fat distribution traits may be different
between women and men of AA as compared to EA. Second, in
terms of methodology, the traits themselves may be measuring
different phenotypic elements of body fat distribution or muscle
Table 4. Interrogation of best SNPs with the smallest p-value within known EA loci in AA for trait WHR ratio adjusted for BMI.
Best SNP results in AA sample
Stage 1 Stage 2 Combined
Genes Best_SNP All1 EAF2 P-val beta SE N3 P4
YRI5 r2
(D9) CEU5 r2 (D9)beta SE P-val6 beta SE P-val P2GC
7
SNPs associated with waist-related trait at significant level
TBX15-WARS2 rs10923714 a/g 0.29 1.8E-04 0.04 0.01 34 1.5E-03 0.49 (1.00) 0.48 (1.00) 0.03 0.02 6.4E-02 0.04 0.01 6.8E-05 1.1E-04
GRB14 rs13389219 t/c 0.71 4.7E-05 20.05 0.01 42 1.2E-03 1.00 (1.00) 0.93 (1.00) 20.02 0.02 2.0E-01 20.04 0.01 9.5E-05 1.4E-04
ADAMTS9 rs13060013 a/c 0.22 3.9E-05 0.05 0.01 95 5.3E-04 0.01 (0.45) 0.33 (1.00) 0.02 0.02 1.2E-01 0.04 0.01 3.8E-05 5.9E-05
LY86 rs1294410 t/c 0.23 6.3E-07 20.06 0.01 130 3.8E-04 0.39 (0.68) 0.83 (0.96) 20.02 0.02 1.1E-01 20.05 0.01 1.0E-06 1.8E-06
RSPO3 rs1936806 t/c 0.29 1.1E-04 0.04 0.01 24 2.1E-03 0.52 (1.00) 0.88 (1.00) 0.00 0.02 4.4E-01 0.03 0.01 8.1E-04 1.1E-03
ITPR2-SSPN rs11048510 c/g 0.23 5.8E-04 0.04 0.01 88 5.7E-04 0.00 (0.25) 0.03 (0.19) 0.04 0.02 1.3E-02 0.04 0.01 4.1E-05 6.0E-05
Further SNPs evaluated in follow up but not achieving significance in combined analysis
LYPLAL1 rs2791547 a/t 0.67 2.0E-03 20.03 0.01 51 9.8E-04 0.00 (0.09) 0.62 (0.95) 20.01 0.02 3.7E-01 20.03 0.01 4.9E-03 6.0E-03
NISCH-STAB1 rs4687612 a/g 0.95 5.3E-03 20.07 0.02 17 2.9E-03 N/A 0.01 (1.00) 20.03 0.04 2.5E-01 20.06 0.02 6.0E-03 7.4E-03
VEGFA rs1761769 t/g 0.30 3.1E-04 20.05 0.01 74 6.8E-04 0.12 (0.70) 0.00 (0.06) 0.01 0.02 2.6E-01 20.03 0.01 5.1E-03 6.3E-03
SNP evaluated but not achieving significance in discovery analysis
DNM3-PIGC rs4916264 t/c 0.66 4.4E-03 20.04 0.02 47 1.1E-03 0.06 (1.00) 0.63 (1.00)
CPEB4 rs2659191 a/g 0.88 1.2E-02 0.04 0.02 92 5.4E-04 N/A 0.16 (1.00)
NFE2L3 rs4719818 t/g 0.21 2.1E-03 20.04 0.01 56 8.9E-04 0.04 (0.42) 0.07 (0.50)
HOXC13 rs7970400 t/c 0.65 4.6E-03 0.03 0.01 62 8.1E-04 0.02 (0.28) 0.02 (0.17)
ZNRF3-KREMEN1 rs16987063 c/g 0.88 1.6E-02 0.06 0.02 47 1.1E-03 0.01 (0.17) N/A
The index SNPs are from Heid et al, Nature Genetics 2010 [17]. Note that Tables 3 and 4 show different information for the same loci (Table 3 for index SNP and
Table 4 for best SNPs with the smallest p-value).
1effect allele/other allele.
2effect allele frequency.
3number of independent (typed) SNPs interrogated in AA sample.
4Bonferroni p-value threshold (0.05/N3).
5HapMAP LD information.
6one-side test p-value.
7P2GC: double GC-corrected p-value.
doi:10.1371/journal.pgen.1003681.t004
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mass in women as compared to men. Abdominal adipose
composition may vary more in EA than AA as EA have greater
visceral adipose tissue than AA of similar gender. Finally,
statistically, for some loci (RSPO3 and ADAMTS9), we cannot rule
out the presence of modest gender differences given the relatively
small sample sizes as compared with other analyses. This is further
reinforced by our power analysis to detect sex-specific associations.
We conducted this power analysis for a common variant
(specifically, MAF of 0.25 here) with an effect size difference of
0.054, which is derived from the largest effect difference indicated
in Table 2 of Heid et al [17]. Using these assumptions, we have
only 6.7% power to detect the variant (MAF of 0.25) with a sample
size of 23564 in our discovery stage and 10.9% power with
combined sample size 33738 from stage 1 and stage 2. This
suggests that we have limited power to detect sexual dimorphism if
it indeed exists.
It is notable that our top SNP at RREB1 is within 1 Mb of
LY86 (lymphocyte antigen 86), one of the 14 novel loci identified
by the GIANT genome-wide association meta-analysis of WHR
[17]. Given the low pairwise linkage disequilibrium and lack of
Figure 3. Regional association plots for all confirmed loci from the GIANT locus interrogation. Each figure is centered by the index SNP
(big red) with rs-number and p-value information (stage 1 only); another big rectangle is the best SNP in African Americans, with information
including MAF=minor allele frequency; linkage disequilibrium information in HapMap YRI and CEU; PD, PF, and PJ are the single GC-corrected p-value
obtained from discovery cohorts only, follow-up cohorts and joint discovery and follow-up data, respectively. Double GC-corrected p-value can be
found in Table 4.
doi:10.1371/journal.pgen.1003681.g003
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change in the association of the beta coefficient upon conditional
analysis in this region, it is likely that there are two independent
genetic effects in this chromosomal region. It is also possible that
these two SNPs may be partially tagging an untyped variant that
explains the underlying association [30–32]. Therefore, fine
mapping or deep sequencing of this region is needed and may
prove relevant to both AA and EA. Our findings also
demonstrate the similarity in the genetic architecture of waist
related traits in EA and AA, as 12 of the 14 previously identified
WHR loci demonstrated direction-consistent effect estimates in
AA as compared to EA participants. For five of these signals
(TBX15-WARS2, GRB14, ADAMTS9, LY86, RSPO3), upon
interrogation of the 250 kb flanking region of the index signal,
we identified a better proxy (r2.0.3 in CEU dataset) SNP of the
presumably underlying biologically important alleles at these loci.
Indeed, these findings may help improve localization of the true
association signal.
rs2075064 is in linkage disequilbrium with variants in the LHX2
and DENND1A genes. LHX2 is a member of the LHX protein
family, the largest group of LIM-domain proteins. LHX proteins
are primarily transcriptional regulators, with a known role in
tissue-specific gene expression. They take part in the determina-
tion of cell lineage and identity in a wide range of tissues, including
the adipocyte differentiation of human adipose-derived stem cells
[33]. Variants in DENND1A gene have been associated with
polycystic ovarian syndrome in both European ancestry [34] and
Chinese women [35]. Taken together, these findings highlight how
future studies can further our understanding of how genes in this
region may contribute to body fat distribution and related obesity
phenotypes.
There are several genes in the region of rs6931262. RREB1
(Ras-responsive element binding protein 1) participates in Ras
signaling and cancer progression in bladder cancer [36] prostate
cancer [37], and melanoma [38]. RREB1 is not known to play a
role in adipose tissue, and SNPs in this gene have previously been
associated with serum urate levels [39]. SSR1, CAGE1, and RIOK1
are also located in this genomic region, although SNPs mapping to
these genes do not appear to be in linkage disequilibrium with the
SNP cluster of interest.
There are several potential implications of this work. First,
these analyses highlight how novel loci for body fat distribu-
tion, above and beyond generalized adiposity, can be
elucidated by performing GWAS in diverse ethnic populations.
Second, we demonstrate some important similarities in the
associations among AA as compared to EA individuals with
regards to the loci uncovered as well as pleiotropy with other
cardio-metabolic phenotypes. Finally, while many of the beta
coefficients were similar in women as compared to men, we
did uncover modest evidence for sexual dimorphism in the
present AA sample.
A major strength of this study is the large sample size of AA
participants, representing the largest study to date for waist-
based phenotypes in AA. This study has similar limitations to
other GWAS performed in AA populations. While the overall
sample size was large, the discovery sample was still consider-
ably smaller than those for GWAS meta-analysis conducted in
samples of primarily EA populations. In the present analysis, to
have 80% power to detect an association that explains 0.1% of
the trait variance at a MAF of 0.25 would require 39581
participants. With our largest WC sample size (n = 23564) in
discovery stage, we have only 28% power to detect common
variant explaining 0.1% of the variance of WC. In addition,
GWAS panels such as the Affymetrix 6.0 chip were largely
designed based on EA populations and have more limited SNP
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coverage for AA samples. For example, one analysis of 76
genes reported that only approximately 45–55% of SNPs were
tagged (r2.0.8) on the Affymetrix 6.0 panel in YRI samples
[40]. Kang and colleagues [41] demonstrated that both local
and global ancestry estimates similarly attenuated spurious
results due to population stratification in their study of AA
ancestry individuals. As with all studies in admixed populations,
while association analyses were adjusted for global population
structure using principal components, there may be residual
population substructure leading to false positive results. Given
the minimal attenuation that we observed with local ancestry
adjustment, our key findings are unlikely to be spurious. We
performed 12 analyses, raising the possibility of false positive
findings using standard significance thresholds. PCSK1 is a bona
fide locus for obesity [42], yet this SNP failed to replicate in
our findings. While we can not rule out power as the reason for
the lack of replication, this signal may also have represented a
false positive finding in our dataset. Heterogeneity between
study samples may limit power, but this is an issue in GWAS
and not unique to the present investigation. After double GC
correction, our findings did not reach genome-wide significance.
However, double GC correction may be overly conservative
[22,23]. Finally, a general limitation in GWAS is that coverage
of rare (MAF,1%) and low frequency (1%,MAF,5%)
variants is poor, and thus associations with rarer variants are
likely missed.
GWAS of body fat distribution traits in a large AA sample
has revealed two loci likely associated with fat distribution, as
well as nominal evidence for association at 6 loci previously
identified among EA individuals. These findings highlight
similarities and differences in the genetic architecture of body
fat distribution in AA and EA individuals, and reinforce the
concept that there are loci for fat distribution above and beyond
generalized adiposity.
Materials & Methods
Phenotype Definition
We analyzed waist-based traits including waist circumference
(WC) and waist-hip ratio (WHR), a measure of body fat
distribution [43]. Details regarding trait acquisition within each
cohort can be found in the Text S1. Individuals less than 20 years
of age were excluded from all analyses. Within each cohort, we
created two sets of residuals for WC and WHR, one adjusted for
age, age2, study site (if applicable) and another additionally
adjusted for BMI. Analyses were conducted separately for men
and women. The raw residuals were then transformed through an
inverse normal function for each subgroup and these transformed
residuals were used as our phenotypes in the association analyses.
The cohorts with related individuals additionally performed sex-
combined analysis. We analyzed four phenotypes: waist circum-
ference (WC), waist circumference adjusted for BMI (WC-BMI),
waist hip ratio (WHR) and waist hip ratio adjusted for BMI
(WHR-BMI).
Samples
We conducted analysis of WC and WHR in up to 33738 and
27489 AA individuals, respectively. Specifically, the analysis
included for WC up to 23,564 individuals and WHR up to
19,744 individuals in stage 1 while 10,174 AA individuals with
WC and 7,745 AA individuals with WHR in stage 2. Stage 1
cohorts were part of the CARe consortium and other cohorts
that were identified with GWAS data at the time the study
started. Stage 2 cohorts with in silico GWAS data were identified
later. Some participating studies, including CFS, Family Heart
Study, GENOA, HUFS, HyperGEN, GeneSTAR, JHS, MESA-
family and SIGNET (REGARDS, SUGAR), are family studies.
The CARe consortium (ARIC, CARDIA, CFS, JHS, MESA)
consists of several population-based studies that included African
ancestry individuals. The WHI study was a clinical trial.
HANDLS is a community-based study. Family Heart Study is
a multicenter family-based study. GeneSTAR is a prospective
study of vascular diseases. GENOA and HYPERGEN are
cohorts of sibships enriched for hypertension. Health ABC is a
random sample of Medicare beneficiaries in and surrounding
Pittsburgh, Pennsylvania, and Memphis, Tennessee. HUFS is a
population-based family study in the Washington, D.C. metro-
politan area. MEC is a prospective cohort study including a
nested breast cancer case-control study. WCHS is a case-control
study of breast cancer in the New York City and New Jersey.
CBCS is population-based case-control study on Breast cancer.
Both MEC and MDA are Prostate cancer case-control studies.
Black Women’s Health Study is an ongoing follow-up study of
59,000 African American women from across the U.S. CHS is a
population-based study of risk factors for CHD and stroke.
REGARDS is an observational cohort and SUGAR is a
community based family studies focusing on Type 2 Diabetes.
Each participating study has obtained institutional review board
approval on research involving human subjects and all subjects
provided written informed consent. Details regarding each
cohort can be found in the Text S1.
Genotyping and Imputation
Genotype information for each cohort is presented in
Supplementary Table S2. As shown in Table 1, the genetic
ancestry of our samples, African American, is also partly from
European Ancestry. Simply using all YRI sample as reference
panel would be inappropriate, given that we generally see an
average of 20% CEU admixture. To better capture the genetic
structure of our samples, all the genotypes from discovery cohorts
were imputed using combined HapMap 1:1 CEU+YRI as
reference panel. This imputation has resulted in an allelic
concordance rate of 95.6%, which is compatible to rates
calculated with the HapMap 2 YRI individuals [44]. Our
follow-up stage (Stage 2) included in silico and de novo follow-
up cohorts. In-silico follow-up studies similarly use the combined
CEU+YRI in HapMap as their reference panel for genotype
imputation. Then the expected allele dosage was used in the
association analysis to account for the uncertainty introduced by
the genotype imputation. More details regarding imputation were
in Supplementary Table S2.
Statistical Methods for Discovery (Stage 1)
In each discovery study, genome-wide tests for association
between SNPs and phenotypes were conducted separately for men
and women using linear regression with principal components
adjustment to adjust for global population substructure. In studies
from families, men and women were also combined for analyses.
Linear mixed effect models, where appropriate, were used to
account for the relatedness in family studies.
In addition to study-specific filters, a centralized quality control
procedure was performed to extensively examine and check all
study-specific results files before meta-analysis. We examined the
plausible values for all reported summary statistics to check for
potential errors. The genomic control lambda (l) value for each set
of results was checked for potential p-value inflation. We analyzed
SNPs with imputation quality scores greater than 0.3 for studies
using MACH or BimBam software, and greater than 0.4 for
GWAS of Body Fat Distribution in African Ancestry
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studies that used other imputation software such as IMPUTE.
Additionally, we filtered out SNPs where the minor allele
frequency times the number of subjects was smaller than or equal
to 5, to ensure robust estimates.
Meta-Analysis
We performed fixed-effects meta-analyses of study-specific
genome-wide association results using the inverse-variance weighted
approach for the traits described above. Three sets of meta-analyses
were conducted for each phenotype using (1) men only results, (2)
women only results, and (3) joint men-only and women-only results
for studies of unrelated individuals, and sex-combined results for
studies with related individuals. The calculated l genomic control
(GC) correction was applied to each cohort’s result. Recent studies
showed that under polygenic inheritance, test statistics in large
meta-analyses are expected to be elevated even when there is no
population sub-structure [22,23]. To avoid an overly conservative
adjustment, we focused on the single GC-corrected result. However,
we also report the double GC-corrected p-value for the joint meta-
analysis of the stage 1 and stage 2 samples.
Local Ancestry Analysis
As a sensitivity analysis, we assessed the impact of local ancestry
by including SNP specific local ancestry estimates as a covariate in
models for genome-wide significant signals in both the CARE and
WHI studies. Locus-specific ancestry (i.e. probabilities of whether
an individual has 0, 1, or 2 alleles of African ancestry at each locus)
was only available for directly genotyped SNPs and was estimated
using a Hidden Markov Model and the local haplotype structure to
detect transitions in ancestry along the genome [45]. We considered
signals robust to adjustment for local ancestry when the Beta was
numerically similar.
Interrogation of GIANT Loci in the Samples of African
Ancestry
We applied a procedure to evaluate the transferability of
association signals across different ethnicities [46]. Specifically, in
addition to validating the previously reported index SNPs identified
in studies of EA participants [17], we interrogated the surrounding
genomic regions in our AA samples. For each reported index EA
SNP, we first examined the results in our AA samples and tested for
consistency of direction, with respect to the beta coefficients of index
SNPs, between EA andAA samples. To accommodate the difference
of LD structure across ethnicities, we then interrogated 6250 kb
regions around the index SNPs and identified the SNP with the
smallest p-value in AA within the interrogated genomic region. The
loci-specific significance threshold was based on Bonferroni correc-
tion, defined as 0.05 divided by the number of independent SNPs
within an interrogated region. SNPs meeting genome-wide
(p,5.061028) or suggestive (5.061028,p,5.061026) in the Stage
1 meta-analysis were carried forward for follow-up in Stage 2 and
joint Stage 1 and 2 meta-analysis. To test the consistency of effect
directions between AA and EA samples, a p-value was calculated
based on the cumulative binomial distribution for the observed or
more extreme number of variants with a consistent direction.
Follow-up Analysis (Stage 2) and Joint Analysis of
Discovery and Follow-up (Stage 1 and 2) Data
An analysis approach consistent with the discovery stage (ie Stage
1), described above, was used for the Stage 2 studies. In this stage, the
variants of interest identified from our analysis of Stage 1 and
interrogation of previously published EA WHR-BMI loci were
followed up in different samples for follow-up meta-analysis and
confirming the association.We then conducted additional jointmeta-
analysis, including studies from both Stage 1 and Stage 2 discovery
and follow-up data. In Stage 2 analysis, the replication was defined as
having a beta coefficient consistent with the discovery stage; follow-
up p-values are thus represented as one-sided tests. For the joint
analysis, we used the standard threshold of p-value,561028 for
genome-wide significance and a locus-specific Bonferroni corrected
threshold for the regions identified by the GIANT consortium.
For newly identified SNPs from both genome-wide association
analyses and previous region interrogation analyses, we performed
sex-specific association analyses and also tested the difference of
meta-analyzed sex-specific beta-estimates (bmen and bwomen) using
the t-statistic
(bmen{bwomen)ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SE2menzSE
2
women{2rSEmenSEwomen
p ,
where r is the Spearman rank correlation coefficient between bmen
and bwomen across all SNPs. Note that we are comparing two
parameters and testing whether their difference is equal to zero. This
is basically the setting of a two-sample test. Although based on our
sample size (n.5000 in combined analysis), the Z-statistic should
work well due to the Central Limit Theory. However, we intended
to conservatively use the t-statistic here to calculate the p-value.
Interrogation of Novel AA Loci in GIANT
We also examined the GIANT consortium results [17] for
evidence of association for the novel loci identified in the AA
samples. We applied similar interrogation procedures detailed in
the previous section of the Interrogation of GIANT Loci in the
samples of African Ancestry. Briefly, we first looked up the
association results for the AA index SNP in GIANT and followed
up with the interrogation of its 6250 kb flanking region. The
significance was evaluated as 0.05 divided by the number of
independent variants within the interrogated region.
Cross-Trait Analyses
For the newly identified SNPs from both GWAS and the
interrogation analysis we performed cross-trait association analyses
of metabolic risk factor and related anthropometric measures,
including BMI [26] , HDL-cholesterol [24], LDL-cholesterol [24],
triglycerides [24], glucose and insulin [25], and height (Christo-
pher Haiman, personal communication), in AA samples for the
newly identified SNPs from both genome-wide association analysis
and the interrogation analysis.
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